Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic offast cancer: the French experience.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples